316 related articles for article (PubMed ID: 9365838)
21. Molecular cytogenetics of chronic myeloid leukemia with atypical t(6;9) (p23;q34) translocation.
Jadayel D; Calabrese G; Min T; van Rhee F; Swansbury GJ; Dyer MJ; Maitland J; Palka G; Catovsky D
Leukemia; 1995 Jun; 9(6):981-7. PubMed ID: 7596189
[TBL] [Abstract][Full Text] [Related]
22. Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping.
Odero MD; Carlson K; Calasanz MJ; Lahortiga I; Chinwalla V; Rowley JD
Genes Chromosomes Cancer; 2001 Jun; 31(2):134-42. PubMed ID: 11319801
[TBL] [Abstract][Full Text] [Related]
23. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
24. Integration of amplified BCR/ABL fusion genes into the short arm of chromosome 17 as a novel mechanism of disease progression in chronic myeloid leukemia.
Metzke-Heidemann S; Harder L; Gesk S; Schoch R; Jenisch S; Grote W; Siebert R; Schlegelberger B
Genes Chromosomes Cancer; 2001 May; 31(1):10-4. PubMed ID: 11284030
[TBL] [Abstract][Full Text] [Related]
25. Variant of ETV6/ABL1 gene is associated with leukemia phenotype.
Park J; Kim M; Lim J; Kim Y; Han K; Kim JS; Lee S; Kim HJ; Min WS
Acta Haematol; 2013; 129(2):78-82. PubMed ID: 23171811
[TBL] [Abstract][Full Text] [Related]
26. Alu and translisin recognition site sequences flanking translocation sites in a novel type of chimeric bcr-abl transcript suggest a possible general mechanism for bcr-abl breakpoints.
Martinelli G; Terragna C; Amabile M; Montefusco V; Testoni N; Ottaviani E; de Vivo A; Mianulli A; Saglio G; Tura S
Haematologica; 2000 Jan; 85(1):40-6. PubMed ID: 10629590
[TBL] [Abstract][Full Text] [Related]
27. [Detection of bcr/abl gene expression on bone marrow cell colonies in chronic myelogenous leukemia by reverse transcriptase-polymerase chain reaction].
Luo Z; Chen H; Luo S; Tang L; Wang J
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(5):418-20. PubMed ID: 12080671
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel fusion gene, TTL, fused to ETV6 in acute lymphoblastic leukemia with t(12;13)(p13;q14), and its implication in leukemogenesis.
Qiao Y; Ogawa S; Hangaishi A; Yuji K; Izutsu K; Kunisato A; Imai Y; Wang L; Hosoya N; Nannya Y; Sato Y; Maki K; Mitani K; Hirai H
Leukemia; 2003 Jun; 17(6):1112-20. PubMed ID: 12764377
[TBL] [Abstract][Full Text] [Related]
29. Two patients with novel BCR/ABL fusion transcripts (e8/a2 and e13/a2) resulting from translocation breakpoints within BCR exons.
How GF; Lim LC; Kulkarni S; Tan LT; Tan P; Cross NC
Br J Haematol; 1999 May; 105(2):434-6. PubMed ID: 10233416
[TBL] [Abstract][Full Text] [Related]
30. Comparative analysis of interphase FISH and RT-PCR to detect bcr-abl translocation in chronic myelogenous leukemia and related disorders.
Tbakhi A; Pettay J; Sreenan JJ; Abdel-Razeq H; Kalaycio M; Hoeltge G; Miller ML; Tubbs RR
Am J Clin Pathol; 1998 Jan; 109(1):16-23. PubMed ID: 9426513
[TBL] [Abstract][Full Text] [Related]
31. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
32. Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.
Aurich J; Duchayne E; Huguet-Rigal F; Bauduer F; Navarro M; Perel Y; Pris J; Caballin MR; Dastugue N
Hematol Cell Ther; 1998 Aug; 40(4):149-58. PubMed ID: 9766919
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity of the 7q36 breakpoints in the t(7;12) involving ETV6 in infant leukemia.
Tosi S; Hughes J; Scherer SW; Nakabayashi K; Harbott J; Haas OA; Cazzaniga G; Biondi A; Kempski H; Kearney L
Genes Chromosomes Cancer; 2003 Oct; 38(2):191-200. PubMed ID: 12939747
[TBL] [Abstract][Full Text] [Related]
34. Identification of a SRC-like tyrosine kinase gene, FRK, fused with ETV6 in a patient with acute myelogenous leukemia carrying a t(6;12)(q21;p13) translocation.
Hosoya N; Qiao Y; Hangaishi A; Wang L; Nannya Y; Sanada M; Kurokawa M; Chiba S; Hirai H; Ogawa S
Genes Chromosomes Cancer; 2005 Mar; 42(3):269-79. PubMed ID: 15611931
[TBL] [Abstract][Full Text] [Related]
35. Unique secondary chromosomal abnormalities are frequently found in the chronic phase of chronic myeloid leukemia in southern Vietnam.
Phan TX; Hoang AV; Huynh VM; Nguyen KT; Nguyen TB; Huynh N; Pham QT; Tran VB; Tran VB; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jul; 168(1):59-68. PubMed ID: 16772122
[TBL] [Abstract][Full Text] [Related]
36. A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemia.
Grand FH; Chase A; Iqbal S; Nguyen DX; Lewis JL; Marley SB; Davidson RJ; Goldman JM; Gordon MY
Genes Chromosomes Cancer; 1998 Oct; 23(2):109-15. PubMed ID: 9739013
[TBL] [Abstract][Full Text] [Related]
37. Acute monocytic leukemia with coexpression of minor BCR-ABL1 and PICALM-MLLT10 fusion genes along with overexpression of HOXA9.
Sindt A; Deau B; Brahim W; Staal A; Visanica S; Villarese P; Rault JP; Macintyre E; Delabesse E
Genes Chromosomes Cancer; 2006 Jun; 45(6):575-82. PubMed ID: 16518848
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of dual color-dual fusion translocation fluorescence in situ hybridization in the detection of bcr/abl fusion gene.
Wu B; Zhou S; Song L; Liu X
Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):364-6. PubMed ID: 12408765
[TBL] [Abstract][Full Text] [Related]
39. Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies.
Tosi S; Giudici G; Mosna G; Harbott J; Specchia G; Grosveld G; Privitera E; Kearney L; Biondi A; Cazzaniga G
Genes Chromosomes Cancer; 1998 Mar; 21(3):223-9. PubMed ID: 9523197
[TBL] [Abstract][Full Text] [Related]
40. High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9.
von Bergh AR; van Drunen E; van Wering ER; van Zutven LJ; Hainmann I; Lönnerholm G; Meijerink JP; Pieters R; Beverloo HB
Genes Chromosomes Cancer; 2006 Aug; 45(8):731-9. PubMed ID: 16646086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]